Effectiveness of Castration Versus Intravenous Estrogen Therapy in Producing Rapid Endocrine Control of Metastatic Cancer of the Prostate
Authors:
- 1 April 1985
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 133 (4) , 620-621
Abstract
Nine men with histologically confirmed stage D cancer of the prostate were evaluated with serial serum testosterone levels after being treated with bilateral orchiectomy or intravenous estrogen. Bilateral orchiectomy produced castrate serum testosterone levels (less than or equal to 50 ng. per 100 ml.) within 2 to 6 hours (mean 3 hours) after surgery. Intravenous estrogen therapy did not consistently produce castrate serum testosterone levels immediately but did significantly decrease testosterone within 12 hours after infusion. Both forms of therapy are safe, produce a clinically effective response and offer advantages for patients with advanced prostatic cancer.Keywords
This publication has 6 references indexed in Scilit:
- Direct Inhibitory Effect of Estrogen on Leydig Cell Function of Hypophysectomized RatsEndocrinology, 1978
- Effect of Hormonal Therapy on Plasma Testosterone Levels in Prostatic CarcinomaBMJ, 1971
- Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A Report to the Committee on Safety of DrugsBMJ, 1970
- Therapy With Orchiectomy or Estrogens or BothJAMA, 1969
- THROMBOEMBOLISM AND ORAL CONTRACEPTIVERS: AN EPIDEMIOLOGIC CASE-CONTROL STUDY12American Journal of Epidemiology, 1969
- Plasma Testosterone Levels in Patients with Prostatic Carcinoma Before and after TreatmentJournal of Urology, 1968